Small peptide TAT-AKPD for treating ischemic brain injury and application of small peptide TAT-AKPD
A TAT-AKPD, ischemic brain injury technology, applied in the field of biomedicine, can solve problems such as ineffective treatment of neuron damage, and achieve the effects of facilitating drug delivery, reducing cell apoptosis, and ensuring effectiveness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] The small peptide TAT-AKPD used in the examples of the present invention for the treatment of ischemic brain injury is designed based on the binding and nitrosylation between Procaspase-7 and XIAP, and its sequence is: H-YGRKKRRQRRR-AKPD-OH , SEQ ID NO.1.
[0021]After cerebral ischemia, endogenous Procaspase-7 undergoes denitrosylation and hydrolysis activation, leading to cell apoptosis. The activity of caspases is regulated by the inhibitor of apoptosis protein family (Inhibitors of apoptosis, IAPs), among which the X-linked inhibitor of apoptosis protein (XIAP) directly binds to Procaspase-7 through its BIR domain. and inhibit its activity. After cerebral ischemia, XIAP undergoes nitrosylation, thereby inhibiting its own anti-apoptotic activity.
[0022] According to the amino acid sequence of the binding site between Procaspase-7 and XIAP, a small peptide TAT-AKPD was designed. The four amino acids of AKPD on Procaspase-7 constitute a motif, which is responsible ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com